Fatty acid trafficking in astrocytes: role of mitochondrial morphology and lipid droplet dynamics
Fatty acid trafficking in astrocytes: role of mitochondrial morphology and lipid droplet dynamics
批准号:
9658631
负责人:
Sarah Cohen
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-04-15 至 2020-12-31
关键词:
AffectAgeAllelesAlzheimer&aposs DiseaseApolipoprotein EAstrocytesAwardBiochemicalBiological AssayBrainCellsCholesterolDementiaDependenceDiabetes MellitusDiseaseEarly InterventionEarly Onset Familial Alzheimer&aposs DiseaseEndoplasmic ReticulumFatty AcidsFatty acid glycerol estersGenesHealthHumanImageImage AnalysisImpairmentInterventionKnockout MiceLate Onset Alzheimer DiseaseLeadLinkLipidsLipoproteinsMeasuresMediatingMetabolicMetabolic PathwayMetabolic syndromeMetabolismMicroscopyMissionMitochondriaMorphologyNerve DegenerationNeuronsObesityOrganellesOxidesPatient-Focused OutcomesPatientsPhasePlayPopulationPrimary Cell CulturesProteinsQuality of lifeResearchRiskRisk FactorsRoleSmall Interfering RNATechniquesTestingTrainingTriglyceridesUnited StatesWorkapolipoprotein E-3apolipoprotein E-4careercomputer programdiabetes riskdisabilityexosomegenetic risk factorimprovedimproved outcomeinsightlink proteinlipid transportmicrovesiclesmitochondrial dysfunctionnovelnovel strategiesoxidationparticlepreventsynaptogenesistrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT: Fatty acid trafficking in astrocytes: role of mitochondrial
morphology and lipid droplet dynamics
As the population of the United States ages, the burden of both dementia and obesity-related
disorders is increasing. There is mounting evidence that obesity, metabolic syndrome, and diabetes can
contribute to the progression of dementias such as Alzheimer's disease. Therefore, it is crucial to
understand the interplay between metabolism and neurodegeneration. A candidate protein linking
metabolism and AD is ApoE. ApoE is involved in the transport of lipids, including fatty acids (FAs) and
cholesterol, in the brain. Of all the identified genetic risk factors for developing late onset AD, a particular
version of the APOE gene called the APOE4 allele is the strongest predictor of risk. How the ApoE4 protein
contributes to the progression of AD is not understood. ApoE is not normally expressed in neurons, but is
expressed in astrocytes. Astrocytes are cells in the brain that supply neurons with many metabolic building
blocks, including FAs. The proposed study will use advanced microscopy techniques to investigate the
storage, metabolism, and trafficking of FAs within astrocytes, and between astrocytes and neurons. In Aim
1, the effect of ApoE on FA storage and metabolism in astrocytes will be examined. The effect of ApoE
expression in astrocytes on the transfer of FAs from astrocytes to neurons will also be tested, and the effect
of FA transfer from astrocytes to neurons on neuronal health and synaptogenesis will be determined. In Aim
2, the hypothesis that ApoE affects mitochondrial morphology and function will be tested. Mitochondria are
the cellular compartment responsible for metabolizing FAs. ApoE has been implicated in mitochondrial
dysfunction, but the mechanism is unclear. Lastly, in Aim 3 the hypothesis that ApoE affects the interaction
between lipid droplets and other cellular compartments will be investigated. Lipid droplets are the cellular
compartment responsible for storing fat. Thus, the exchange of FAs between lipid droplets and other cellular
compartments responsible for synthesizing and oxidizing FAs is likely to have an impact on FA trafficking
within astrocytes, and between astrocytes and neurons. Together, these studies will provide insight into the
links between metabolism and neurodegeneration. This could lead to new approaches for early intervention
to slow or prevent Alzheimer's disease, for example by targeting metabolic pathways that control the
storage or trafficking of FAs in astrocytes. Such interventions have the potential to dramatically improve the
quality of life of patients suffering from Alzheimer's disease and other dementias.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Assessing the role of APOE in glial lipid droplet metabolism and function
-
批准号:10645540
-
项目类别:
-
资助金额:$58.56万
-
财政年份:2023
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:10164808
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:10587303
-
项目类别:
-
资助金额:$11.67万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:10618338
-
项目类别:
-
资助金额:$44.7万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:9980935
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:10404018
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
Molecular mechanisms of intra- and inter-cellular fatty acid trafficking
-
批准号:9796895
-
项目类别:
-
资助金额:$38.09万
-
财政年份:2019
-
负责人:Sarah Cohen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: